Francis Burrows's most recent trade in Kura Oncology Inc was a trade of 1,311 Common Stock done at an average price of $8.5 . Disclosure was reported to the exchange on Jan. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.46 per share. | 27 Jan 2026 | 1,311 | 32,424 (0%) | 0% | 8.5 | 11,092 | Common Stock |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2025 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 18 Dec 2025 | 35,000 | 57,461 (0%) | 0% | 4.8 | 168,000 | Common Stock |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.78 per share. | 18 Dec 2025 | 23,726 | 33,735 (0%) | 0% | 9.8 | 231,931 | Common Stock |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 1,320 | 20,705 (0%) | 0% | 7.9 | 10,391 | Common Stock |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 846 | 22,025 (0%) | 0% | 7.9 | 6,660 | Common Stock |
| Kura Oncology Inc | Francis Burrows | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 185,000 | 185,000 | - | - | Option to purchase common stock |